These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 22245188)
1. Effect of gold marker seeds on magnetic resonance spectroscopy of the prostate. Hossain M; Schirmer T; Richardson T; Chen L; Buyyounouski MK; Ma CM Int J Radiat Oncol Biol Phys; 2012 May; 83(1):451-8. PubMed ID: 22245188 [TBL] [Abstract][Full Text] [Related]
2. A phase and frequency alignment protocol for 1H MRSI data of the prostate. Wright AJ; Buydens LM; Heerschap A NMR Biomed; 2012 May; 25(5):755-65. PubMed ID: 21953616 [TBL] [Abstract][Full Text] [Related]
3. Temporal B0 field variation effects on MRSI of the human prostate at 7 T and feasibility of correction using an internal field probe. Arteaga de Castro CS; Boer VO; Luttje MP; van der Velden TA; Bhogal A; van Vulpen M; Luijten PR; van der Heide UA; Klomp DW NMR Biomed; 2014 Nov; 27(11):1353-60. PubMed ID: 25212868 [TBL] [Abstract][Full Text] [Related]
4. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. Kurhanewicz J; Vigneron DB; Hricak H; Narayan P; Carroll P; Nelson SJ Radiology; 1996 Mar; 198(3):795-805. PubMed ID: 8628874 [TBL] [Abstract][Full Text] [Related]
5. Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging. Zelefsky MJ; Cohen G; Zakian KL; Dyke J; Koutcher JA; Hricak H; Schwartz L; Zaider M Cancer J; 2000; 6(4):249-55. PubMed ID: 11038145 [TBL] [Abstract][Full Text] [Related]
6. Assessment of prostatic fiducial marker introduction: patient morbidity, staff satisfaction and improved treatment field placement. Brown S; Lehman M; Ferrari-Anderson J; Glyde A; Burmeister E; Nicol D J Med Imaging Radiat Oncol; 2011 Aug; 55(4):417-24. PubMed ID: 21843178 [TBL] [Abstract][Full Text] [Related]
7. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. Kurhanewicz J; Vigneron DB; Nelson SJ; Hricak H; MacDonald JM; Konety B; Narayan P Urology; 1995 Mar; 45(3):459-66. PubMed ID: 7533458 [TBL] [Abstract][Full Text] [Related]
8. MR Spectroscopy in Prostate Cancer: New Algorithms to Optimize Metabolite Quantification. Bellomo G; Marcocci F; Bianchini D; Mezzenga E; D'Errico V; Menghi E; Zannoli R; Sarnelli A PLoS One; 2016; 11(11):e0165730. PubMed ID: 27832096 [TBL] [Abstract][Full Text] [Related]
9. MRI spectroscopy in screening of prostate cancer. Goeb K; Engehausen DG; Krause FS; Hollenbach HP; Niedobitek G; Buettner M; Frangou P; Engelhard K Anticancer Res; 2007; 27(1B):687-93. PubMed ID: 17348461 [TBL] [Abstract][Full Text] [Related]
10. [1H magnetic resonance spectroscopy of the prostate]. Mueller-Lisse UG; Scherr M Radiologe; 2003 Jun; 43(6):481-8. PubMed ID: 12827263 [TBL] [Abstract][Full Text] [Related]
11. Reproducibility of 3D 1H MR spectroscopic imaging of the prostate at 1.5T. Lagemaat MW; Zechmann CM; Fütterer JJ; Weiland E; Lu J; Villeirs GM; Holshouser BA; van Hecke P; Lemort M; Schlemmer HP; Barentsz JO; Roell SO; Heerschap A; Scheenen TW J Magn Reson Imaging; 2012 Jan; 35(1):166-73. PubMed ID: 21960013 [TBL] [Abstract][Full Text] [Related]
12. Three-dimensional proton magnetic resonance spectroscopic imaging with and without an endorectal coil: a prostate phantom study. Ma C; Chen L; Scheenen TW; Lu J; Wang J Acta Radiol; 2015 Nov; 56(11):1342-9. PubMed ID: 25348479 [TBL] [Abstract][Full Text] [Related]
13. 1H-MRSI of prostate cancer: the relationship between metabolite ratio and tumor proliferation. Wang XZ; Wang B; Gao ZQ; Liu JG; Liu ZQ; Niu QL; Sun ZK; Yuan YX Eur J Radiol; 2010 Feb; 73(2):345-51. PubMed ID: 19070978 [TBL] [Abstract][Full Text] [Related]
14. High-resolution 3D MR spectroscopic imaging of the prostate at 3 T with the MLEV-PRESS sequence. Chen AP; Cunningham CH; Kurhanewicz J; Xu D; Hurd RE; Pauly JM; Carvajal L; Karpodinis K; Vigneron DB Magn Reson Imaging; 2006 Sep; 24(7):825-32. PubMed ID: 16916699 [TBL] [Abstract][Full Text] [Related]
16. In vivo prostate magnetic resonance spectroscopic imaging using two-dimensional J-resolved PRESS at 3 T. Kim DH; Margolis D; Xing L; Daniel B; Spielman D Magn Reson Med; 2005 May; 53(5):1177-82. PubMed ID: 15844143 [TBL] [Abstract][Full Text] [Related]
17. Quantification of prostate MRSI data by model-based time domain fitting and frequency domain analysis. Pels P; Ozturk-Isik E; Swanson MG; Vanhamme L; Kurhanewicz J; Nelson SJ; Van Huffel S NMR Biomed; 2006 Apr; 19(2):188-97. PubMed ID: 16411280 [TBL] [Abstract][Full Text] [Related]
18. Accuracy of seed reconstruction in prostate postplanning studied with a CT- and MRI-compatible phantom. De Brabandere M; Kirisits C; Peeters R; Haustermans K; Van den Heuvel F Radiother Oncol; 2006 May; 79(2):190-7. PubMed ID: 16707176 [TBL] [Abstract][Full Text] [Related]
19. [Spectroscopic imaging (1H-2D-CSI) of the prostate: sequence optimization and correlation with histopathological results]. Stanka M; Eltze E; Semjonow A; Sievert KD; Maier A; Pfleiderer B Rofo; 2000 Jul; 172(7):623-9. PubMed ID: 10962989 [TBL] [Abstract][Full Text] [Related]
20. Sequence design for magnetic resonance spectroscopic imaging of prostate cancer at 3 T. Cunningham CH; Vigneron DB; Marjanska M; Chen AP; Xu D; Hurd RE; Kurhanewicz J; Garwood M; Pauly JM Magn Reson Med; 2005 May; 53(5):1033-9. PubMed ID: 15844147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]